Objectives: (1) To assess the prescription patterns of antidiabetic drugs in Type 2 diabetes patients in Rural Central India. (2) To assess compliance with American Diabetes Association guidelines for the management of Type 2 diabetes. (3) To assess the clinical and demographic characteristics, such as age, gender, comorbidities, and lifestyle. (4) To assess glycemic control based on glycated hemoglobin (HbA1c) levels. (5) Determine the most commonly prescribed antidiabetic treatments and drug selection factors. Methods: A retrospective observational study of 120 patients evaluated demographics, lifestyle characteristics, comorbidities, HbA1c, and prescribed antidiabetic treatments, with emphasis on guideline compliance. Results: The majority of participants (70.87%) were aged 41–60 years, with a near-equal gender distribution. While 89.17% adhered to lifestyle modifications, 54.17% were overweight, and 12.50% were obese. Risk factors included smoking (35.83%) and alcohol consumption (14.17%). HbA1c levels indicated that 55% had moderate glycemic control (6.5–8), though 16.67% had levels above 10. Common comorbidities included hypertension (45.00%), dyslipidemia (35.00%), and cardiovascular disease (22.50%). The most frequently prescribed antidiabetic therapy was the fixed-dose combination of glimepiride and metformin (54%), with insulin therapy used in 30% of cases. Adherence to American Diabetes Association guidelines was high (90%), though 10% showed non-adherence due to patient refusal or off-guideline practices. Conclusion: The study underscores the importance of holistic diabetes care, addressing lifestyle, pharmacological, and guideline adherence to improve outcomes.
Amin et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: